Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
Abstract Background Despite advances in treatment, recurrence and mortality rates from breast cancer (BrCa) continue to rise, clinical effectiveness is limited, and prognosis remains disappointing, especially for patients with HER2-positive, triple-negative, or advanced breast cancer. Based on cupro...
Saved in:
Main Authors: | Chun Li (Author), Yicong Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
by: Lin Pang, et al.
Published: (2023) -
Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
by: Zhou Q, et al.
Published: (2024) -
Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
by: Tongjin Xie, et al.
Published: (2022) -
LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
by: Rui Huang, et al.
Published: (2020) -
An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
by: Zhou Y, et al.
Published: (2024)